CBP501 Affinity Peptide - CAS 1351804-17-5

CBP501 Affinity Peptide, a Chk kinase inhibitor, disrupts G2 arrest triggered by DNA-damaging agents and is utilized in cancer research [1].

Chk

Cell Cycle/Checkpoint

1351782

C68H119N21O25S

1662.86

[C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC(N)=O)N)=O)CO)=O)CC(O)=O)=O)CS)=O)[C@H](CC)C)=O)[C@H](CC)C)=O)CO)=O)CCCNC(=N)N)=O)CCCCN)=O)[C@H](CC)C)=O)(C(N[C@H](C(N[C@H](C(N[C@@H](CCC(O)=O)C(O)=O)=O)CCCCN)=O)CCC(N)=O)=O)CCC(O)=O

-20°C

Ice Packs

Peptide